CDG Biotech Corporation – Trademark Portfolio

Entity Type: 03

CDG Biotech Corporation holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include Q-STRIP. The owner is based in Westlake Village, CA.

Unit 106

Via Colinas

Westlake Village, CA 91362

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Q-STRIP
Q-STRIP
Registered 2018

Trademark Classifications

CDG Biotech Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does CDG Biotech Corporation have?

CDG Biotech Corporation has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does CDG Biotech Corporation file in?

CDG Biotech Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 10 (Medical Apparatus). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are CDG Biotech Corporation's most well-known trademarks?

CDG Biotech Corporation's registered trademark portfolio includes well-known marks such as Q-STRIP. These are among 1 currently registered trademark in the portfolio.

What is CDG Biotech Corporation's trademark registration success rate?

CDG Biotech Corporation has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.